These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33563664)

  • 1. Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression.
    Tavernari D; Battistello E; Dheilly E; Petruzzella AS; Mina M; Sordet-Dessimoz J; Peters S; Krueger T; Gfeller D; Riggi N; Oricchio E; Letovanec I; Ciriello G
    Cancer Discov; 2021 Jun; 11(6):1490-1507. PubMed ID: 33563664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas.
    Dietz S; Lifshitz A; Kazdal D; Harms A; Endris V; Winter H; Stenzinger A; Warth A; Sill M; Tanay A; Sültmann H
    Int J Cancer; 2019 Mar; 144(5):1061-1072. PubMed ID: 30350867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional patterns reveal tumor histologic heterogeneity and immunotherapy response in lung adenocarcinoma.
    Jiao M; Liu H; Liu X
    Front Immunol; 2022; 13():957751. PubMed ID: 36003401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Intratumor Heterogeneity Remodels the Immune Microenvironment and Induces Immune Evasion in Brain Metastasis of Lung Cancer.
    Wang X; Bai H; Zhang J; Wang Z; Duan J; Cai H; Cao Z; Lin Q; Ding X; Sun Y; Zhang W; Xu X; Chen H; Zhang D; Feng X; Wan J; Zhang J; He J; Wang J
    J Thorac Oncol; 2024 Feb; 19(2):252-272. PubMed ID: 37717855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
    Zito Marino F; Liguori G; Aquino G; La Mantia E; Bosari S; Ferrero S; Rosso L; Gaudioso G; De Rosa N; Scrima M; Martucci N; La Rocca A; Normanno N; Morabito A; Rocco G; Botti G; Franco R
    PLoS One; 2015; 10(9):e0139264. PubMed ID: 26422230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts.
    Kazdal D; Endris V; Allgäuer M; Kriegsmann M; Leichsenring J; Volckmar AL; Harms A; Kirchner M; Kriegsmann K; Neumann O; Brandt R; Talla SB; Rempel E; Ploeger C; von Winterfeld M; Christopoulos P; Merino DM; Stewart M; Allen J; Bischoff H; Meister M; Muley T; Herth F; Penzel R; Warth A; Winter H; Fröhling S; Peters S; Swanton C; Thomas M; Schirmacher P; Budczies J; Stenzinger A
    J Thorac Oncol; 2019 Nov; 14(11):1935-1947. PubMed ID: 31349062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.
    Quek K; Li J; Estecio M; Zhang J; Fujimoto J; Roarty E; Little L; Chow CW; Song X; Behrens C; Chen T; William WN; Swisher S; Heymach J; Wistuba I; Zhang J; Futreal A; Zhang J
    Oncotarget; 2017 Mar; 8(13):21994-22002. PubMed ID: 28423542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
    Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
    Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
    Reuben A; Gittelman R; Gao J; Zhang J; Yusko EC; Wu CJ; Emerson R; Zhang J; Tipton C; Li J; Quek K; Gopalakrishnan V; Chen R; Vence LM; Cascone T; Vignali M; Fujimoto J; Rodriguez-Canales J; Parra ER; Little LD; Gumbs C; Forget MA; Federico L; Haymaker C; Behrens C; Benzeno S; Bernatchez C; Sepesi B; Gibbons DL; Wargo JA; William WN; Swisher S; Heymach JV; Robins H; Lee JJ; Sharma P; Allison JP; Futreal PA; Wistuba II; Zhang J
    Cancer Discov; 2017 Oct; 7(10):1088-1097. PubMed ID: 28733428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report.
    Wu L; Kang P; Tao S; Zhao Z; Chen L; Xiao Y; Tan Q
    BMC Med Genomics; 2020 Jan; 13(1):15. PubMed ID: 32005243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.
    Zhang J; Fujimoto J; Zhang J; Wedge DC; Song X; Zhang J; Seth S; Chow CW; Cao Y; Gumbs C; Gold KA; Kalhor N; Little L; Mahadeshwar H; Moran C; Protopopov A; Sun H; Tang J; Wu X; Ye Y; William WN; Lee JJ; Heymach JV; Hong WK; Swisher S; Wistuba II; Futreal PA
    Science; 2014 Oct; 346(6206):256-9. PubMed ID: 25301631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.
    Dietz S; Harms A; Endris V; Eichhorn F; Kriegsmann M; Longuespée R; Stenzinger A; Sültmann H; Warth A; Kazdal D
    Int J Cancer; 2017 Nov; 141(9):1841-1848. PubMed ID: 28699162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single-Cell Transcriptomics.
    Zhang X; Liang B; Huang Y; Meng H; Li Z; Du J; Zhou L; Zhong Y; Wang B; Lin X; Yu G; Chen X; Lu W; Chen ZS; Yang X; Huang Z
    Adv Sci (Weinh); 2023 Dec; 10(36):e2303753. PubMed ID: 37991139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.
    Solis LM; Behrens C; Raso MG; Lin HY; Kadara H; Yuan P; Galindo H; Tang X; Lee JJ; Kalhor N; Wistuba II; Moran CA
    Cancer; 2012 Jun; 118(11):2889-99. PubMed ID: 22020674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
    Chen G; Dong Z; Wu D; Chen Y
    J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma.
    Dolgalev I; Zhou H; Murrell N; Le H; Sakellaropoulos T; Coudray N; Zhu K; Vasudevaraja V; Yeaton A; Goparaju C; Li Y; Sulaiman I; Tsay JJ; Meyn P; Mohamed H; Sydney I; Shiomi T; Ramaswami S; Narula N; Kulicke R; Davis FP; Stransky N; Smolen GA; Cheng WY; Cai J; Punekar S; Velcheti V; Sterman DH; Poirier JT; Neel B; Wong KK; Chiriboga L; Heguy A; Papagiannakopoulos T; Nadorp B; Snuderl M; Segal LN; Moreira AL; Pass HI; Tsirigos A
    Nat Commun; 2023 Nov; 14(1):6764. PubMed ID: 37938580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
    Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
    Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.
    Tomonaga N; Nakamura Y; Yamaguchi H; Ikeda T; Mizoguchi K; Motoshima K; Doi S; Nakatomi K; Iida T; Hayashi T; Nagayasu T; Tsukamoto K; Kohno S
    Clin Lung Cancer; 2013 Sep; 14(5):521-6. PubMed ID: 23786997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.